abstract |
FIELD: pharmaceutical industry; biology; medicine.SUBSTANCE: invention relates to medicine, pharmacology and biology and concerns the use of 1- (germatran-1-yl) -1-oxyethylamine of the formula:as a means that inhibits the total (total) activity of the lysosomal lipolytic enzyme - acidic phospholipase A1.EFFECT: invention allows expanding the arsenal of drugs against hyperlipidemia, preventing atherosclerotic lesions of blood vessels.4 cl, 2 tbl, 1 ex |